JNJ-79635322A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Sponsor:

Janssen Research & Development, LLC

Code:

NCT05652335

Conditions

Relapsed or Refractory Multiple Myeloma

Previously Treated Amyloid Light-chain (AL) Amyloidosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

JNJ-79635322

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by Janssen Research & Development, LLC on 2026-07-06.